EU greenlights Onward’s ARC-EX system for spinal cord injury patients

ARC‑EX is the first system to receive a CE Mark in Europe specifically for improving hand and arm strength and sensation in adults with chronic, incomplete spinal cord injury.

Secured under the European Union’s Medical Device Regulation (EU MDR), ARC-EX delivers electrical spinal cord stimulation (SCS) for SCI via electrodes attached to the neck, presenting a non-invasive option.

The Netherlands-headquartered company’s ARC-EX is the first SCI-approved device in Europe that is specifically indicated for improving hand strength and sensation in adults with SCI and is promoted for use in conjunction with standard rehabilitation practices. It joins other SCIs on the European market, including Aneuvo’s ExaStim, which is indicated for restoring motor function in individuals with chronic SCI.

Sign up for Blog Updates